News > DCGI allows Serum to enroll 7-11 year olds in COVID vaccine trial

DCGI allows Serum to enroll 7-11 year olds in COVID vaccine trial

Medical Buyer | 28/09/2021 07:38 PM | Click to read full article

India’s drug regulator on Tuesday allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its COVID-19 vaccine trial as the country prepares to protect children from the coronavirus.

“After detailed deliberation, the committee recommended for allowing enrolment of subjects of 7 to 11 years of age group as per the protocol,” a subject expert panel of the Central Drugs Standard Control Organization said.